Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Fibromyalgia in HIV-1 Patients
NCT00552682Phase 3Completed
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Jan 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in fibromyalgia (FM) comparing Duloxetine with Standard of Care (2 arms). Primary endpoint: Variation in pain measured using the Brief Pain Inventory questionnaire at 48 weeks. Started Jan 2007; status: completed.
02
Drugs
duloxetine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00552682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00552682.